DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
The Californer/10223841

SAN RAMON, Calif. - Californer -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data into intelligence, today announced the appointment of Krish Ghosh as Executive Vice President and General Manager, Life Sciences, reporting to David Dvorak, the Chairman and Chief Executive Officer of DeepThink Health.

Mr. Ghosh is a seasoned business leader with extensive operating experience in pharmaceutical, contract research organization (CRO) and molecular laboratory companies. Most recently, he served as the Chief Analytics Officer and General Manager of BioPharma Solutions at Sema4 from 2019 to 2022. Mr. Ghosh also previously held several executive positions with LabCorp/Covance from 2006 to 2019, including Vice President of Informatics and Resource Management, in addition to having served in senior management roles at Pfizer and Bristol-Myers Squibb.

More on The Californer

• Farther's Michael Lee Named One of InvestmentNews' Rising Stars of 2025
• Growing Demand for EVA Mats Signals Shift in Car Interior Market
• 4th Annual Holidays In The Village, A European Marketplace
• Moorpark College Named 2025 Pathway Champion for Driving Equity in Transfer Success
• MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna

"We are delighted to have Krish join DeepThink Health," stated David Dvorak. "His practical experience with artificial intelligence, big data analytics and informatics within life sciences is an excellent fit for our Company. Krish's depth of knowledge in areas such as research and development and clinical trial optimization will enable us to fully leverage our unique solutions to help customers unlock the enormous potential of complex health data."

Mr. Ghosh said, "DeepThink Health has developed and matured a differentiated set of solutions to de-identify, curate and structure complex clinical, genomic and other contextual health datasets at scale. DeepThink's AI-powered solutions are well positioned to advance drug development and patient care by transforming siloed and unstructured health data into actionable intelligence. I am very excited to work with the team at DeepThink to position these capabilities successfully within the life sciences market."

More on The Californer

• Chera TV: The Female-Led Platform Redefining Hollywood's Next Era of Storytelling
• California Student Aid Commission Launches 2026-27 Statewide Financial Aid Cycle at Ventura College
• California: Governor Newsom supports workers as Trump's shutdown hurts the economy
• California strengthens its pipeline for good-paying jobs, providing $25 million to train more than 22,000 workers through apprenticeship programs
• Why Voting "No on Prop 50" Makes Sense

Mr. Ghosh holds a Ph.D. in Statistics from Temple University and earned an MBA in Finance from the Fox School of Business at Temple University.

About DeepThink Health

DeepThink Health offers an innovative Precision Intelligence Platform that extracts, de-identifies and curates complex clinical, genomic and other contextual health datasets with unmatched accuracy and precision. Our platform transforms unstructured data into actionable intelligence at scale. DeepThink's solutions then apply advanced analytics and proprietary machine learning to enable a variety of use cases across the healthcare spectrum. Our team has extensive experience and a track record of success in leading healthcare technology companies.

For more information visit   www.deepthinkhealth.com